![](/images/general/no_picture/200_user.png)
Carl D Friedman
Examiner (ID: 6600)
Most Active Art Unit | 3504 |
Art Unit(s) | 2403, 2407, 3635, 3621, 3505, 3632, 3504 |
Total Applications | 1006 |
Issued Applications | 891 |
Pending Applications | 6 |
Abandoned Applications | 109 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 9615686
[patent_doc_number] => 20140205543
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-24
[patent_title] => 'METHOD FOR DIAGNOSING OR TREATING TUMORS USING SPHINGOMYELIN CONTAINING LIPOSOMES'
[patent_app_type] => utility
[patent_app_number] => 14/162494
[patent_app_country] => US
[patent_app_date] => 2014-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 7923
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14162494
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/162494 | METHOD FOR DIAGNOSING OR TREATING TUMORS USING SPHINGOMYELIN CONTAINING LIPOSOMES | Jan 22, 2014 | Abandoned |
Array
(
[id] => 10435877
[patent_doc_number] => 20150320889
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-12
[patent_title] => 'Vectorised Magnetic Emulsion'
[patent_app_type] => utility
[patent_app_number] => 14/762064
[patent_app_country] => US
[patent_app_date] => 2014-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 15556
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14762064
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/762064 | Vectorised Magnetic Emulsion | Jan 22, 2014 | Abandoned |
Array
(
[id] => 10654798
[patent_doc_number] => 20160000942
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-07
[patent_title] => 'MRI CONTRAST AGENT INCLUDING T1 CONTRAST MATERIAL COATED ON SURFACE OF NANOPARTICLE SUPPORT'
[patent_app_type] => utility
[patent_app_number] => 14/759288
[patent_app_country] => US
[patent_app_date] => 2014-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7572
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14759288
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/759288 | MRI CONTRAST AGENT INCLUDING T1 CONTRAST MATERIAL COATED ON SURFACE OF NANOPARTICLE SUPPORT | Jan 2, 2014 | Abandoned |
Array
(
[id] => 10458082
[patent_doc_number] => 20150343097
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-03
[patent_title] => 'GAS-FILLED MICROVESICLES'
[patent_app_type] => utility
[patent_app_number] => 14/653793
[patent_app_country] => US
[patent_app_date] => 2013-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9321
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14653793
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/653793 | Gas-filled microvesicles | Dec 18, 2013 | Issued |
Array
(
[id] => 10458064
[patent_doc_number] => 20150343079
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-03
[patent_title] => 'Ultrasound contrast agent with nanoparticles including drug and method for preparing the same'
[patent_app_type] => utility
[patent_app_number] => 14/437816
[patent_app_country] => US
[patent_app_date] => 2013-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 4319
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14437816
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/437816 | Ultrasound contrast agent with nanoparticles including drug and method for preparing the same | Sep 26, 2013 | Abandoned |
Array
(
[id] => 9213047
[patent_doc_number] => 20140012224
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-09
[patent_title] => 'Targeted hollow gold nanostructures and methods of use'
[patent_app_type] => utility
[patent_app_number] => 13/987689
[patent_app_country] => US
[patent_app_date] => 2013-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 32409
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13987689
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/987689 | Targeted hollow gold nanostructures and methods of use | Aug 20, 2013 | Abandoned |
Array
(
[id] => 10289275
[patent_doc_number] => 20150174273
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-25
[patent_title] => 'IMAGING AND THERAPEUTIC METHODS FOR TREATING PARATHYROID TUMORS'
[patent_app_type] => utility
[patent_app_number] => 14/416694
[patent_app_country] => US
[patent_app_date] => 2013-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6783
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14416694
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/416694 | IMAGING AND THERAPEUTIC METHODS FOR TREATING PARATHYROID TUMORS | Jul 23, 2013 | Abandoned |
Array
(
[id] => 10262279
[patent_doc_number] => 20150147276
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-28
[patent_title] => 'NANOTHERAPEUTICS FOR DRUG TARGETING'
[patent_app_type] => utility
[patent_app_number] => 14/405251
[patent_app_country] => US
[patent_app_date] => 2013-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 56932
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14405251
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/405251 | NANOTHERAPEUTICS FOR DRUG TARGETING | Jun 6, 2013 | Abandoned |
Array
(
[id] => 9173853
[patent_doc_number] => 20130315838
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-28
[patent_title] => 'BIOMATERIALS SUITABLE FOR USE AS DRUG ELUTING, MAGNETIC RESONANCE IMAGING DETECTABLE IMPLANTS FOR VASCULAR OCCLUSION'
[patent_app_type] => utility
[patent_app_number] => 13/900796
[patent_app_country] => US
[patent_app_date] => 2013-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 11238
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13900796
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/900796 | Biomaterials suitable for use as drug eluting, magnetic resonance imaging detectable implants for vascular occlusion | May 22, 2013 | Issued |
Array
(
[id] => 13011841
[patent_doc_number] => 10029021
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-24
[patent_title] => Polymer, contrast agent for nuclear magnetic resonance analysis or magnetic resonance imaging using the polymer, compound and method of nuclear magnetic resonance analysis and method of magnetic resonance imaging using the polymer
[patent_app_type] => utility
[patent_app_number] => 14/395193
[patent_app_country] => US
[patent_app_date] => 2013-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 21
[patent_no_of_words] => 10197
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14395193
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/395193 | Polymer, contrast agent for nuclear magnetic resonance analysis or magnetic resonance imaging using the polymer, compound and method of nuclear magnetic resonance analysis and method of magnetic resonance imaging using the polymer | May 21, 2013 | Issued |
Array
(
[id] => 10705561
[patent_doc_number] => 20160051708
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-25
[patent_title] => 'Metal Oxide Nanoparticle-Based Magnetic Resonance Imaging Contrast Agent with a Central Cavity'
[patent_app_type] => utility
[patent_app_number] => 14/782552
[patent_app_country] => US
[patent_app_date] => 2013-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 5073
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14782552
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/782552 | Metal Oxide Nanoparticle-Based Magnetic Resonance Imaging Contrast Agent with a Central Cavity | Apr 4, 2013 | Abandoned |
Array
(
[id] => 10705560
[patent_doc_number] => 20160051707
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-25
[patent_title] => 'Metal Oxide Nanoparticle-Based T1-T2 Dual-Mode Magnetic Resonance Imaging Contrast Agent'
[patent_app_type] => utility
[patent_app_number] => 14/782481
[patent_app_country] => US
[patent_app_date] => 2013-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 4423
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14782481
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/782481 | Metal Oxide Nanoparticle-Based T1-T2 Dual-Mode Magnetic Resonance Imaging Contrast Agent | Apr 4, 2013 | Abandoned |
Array
(
[id] => 11479453
[patent_doc_number] => 09585975
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-03-07
[patent_title] => 'MRI contrast agents'
[patent_app_type] => utility
[patent_app_number] => 13/853324
[patent_app_country] => US
[patent_app_date] => 2013-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 14
[patent_no_of_words] => 9150
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13853324
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/853324 | MRI contrast agents | Mar 28, 2013 | Issued |
Array
(
[id] => 10974150
[patent_doc_number] => 20140377185
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2014-12-25
[patent_title] => 'STABILIZED FORMULATIONS CONTAINING IODINATED CONTRAST AGENTS AND CYCLODEXTRINS'
[patent_app_type] => utility
[patent_app_number] => 13/787495
[patent_app_country] => US
[patent_app_date] => 2013-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16276
[patent_no_of_claims] => 79
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13787495
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/787495 | STABILIZED FORMULATIONS CONTAINING IODINATED CONTRAST AGENTS AND CYCLODEXTRINS | Mar 5, 2013 | Abandoned |
Array
(
[id] => 10332997
[patent_doc_number] => 20150218001
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-06
[patent_title] => 'PREPARATION METHOD OF HETEROATOM DOPED MULTIFUNCTIONAL CARBON QUANTUM DOT AND APPLICATION THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/420078
[patent_app_country] => US
[patent_app_date] => 2013-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 18734
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14420078
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/420078 | PREPARATION METHOD OF HETEROATOM DOPED MULTIFUNCTIONAL CARBON QUANTUM DOT AND APPLICATION THEREOF | Mar 5, 2013 | Abandoned |
Array
(
[id] => 10974150
[patent_doc_number] => 20140377185
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2014-12-25
[patent_title] => 'STABILIZED FORMULATIONS CONTAINING IODINATED CONTRAST AGENTS AND CYCLODEXTRINS'
[patent_app_type] => utility
[patent_app_number] => 13/787495
[patent_app_country] => US
[patent_app_date] => 2013-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16276
[patent_no_of_claims] => 79
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13787495
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/787495 | STABILIZED FORMULATIONS CONTAINING IODINATED CONTRAST AGENTS AND CYCLODEXTRINS | Mar 5, 2013 | Abandoned |
Array
(
[id] => 9908914
[patent_doc_number] => 20150064115
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-05
[patent_title] => 'NEUROPHILIC NANOPARTICLES'
[patent_app_type] => utility
[patent_app_number] => 14/390584
[patent_app_country] => US
[patent_app_date] => 2013-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 18591
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14390584
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/390584 | NEUROPHILIC NANOPARTICLES | Mar 5, 2013 | Abandoned |
Array
(
[id] => 9338291
[patent_doc_number] => 20140065073
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-06
[patent_title] => 'IMAGING AGENTS AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/778887
[patent_app_country] => US
[patent_app_date] => 2013-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 8424
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13778887
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/778887 | Imaging agents and methods of use thereof | Feb 26, 2013 | Issued |
Array
(
[id] => 9149234
[patent_doc_number] => 20130303757
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-14
[patent_title] => 'POLYMER PRECURSORS OF RADIOLABELED COMPOUNDS, AND METHODS OF MAKING AND USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 13/776039
[patent_app_country] => US
[patent_app_date] => 2013-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 14751
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13776039
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/776039 | Polymer precursors of radiolabeled compounds, and methods of making and using the same | Feb 24, 2013 | Issued |
Array
(
[id] => 9656191
[patent_doc_number] => 20140227196
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-14
[patent_title] => 'PORPHYRIN COMPOUNDS AND THEIR USE AS MRI CONTRAST AGENTS'
[patent_app_type] => utility
[patent_app_number] => 13/765458
[patent_app_country] => US
[patent_app_date] => 2013-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 18563
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13765458
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/765458 | Porphyrin compounds and their use as MRI contrast agents | Feb 11, 2013 | Issued |